Barclays PLC Reduces Stock Holdings in Colgate-Palmolive Company $CL

Barclays PLC decreased its position in Colgate-Palmolive Company (NYSE:CL) by 9.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,695,237 shares of the company’s stock after selling 280,939 shares during the period. Barclays PLC’s holdings in Colgate-Palmolive were worth $212,978,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Vanguard Group Inc. raised its holdings in Colgate-Palmolive by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 83,947,987 shares of the company’s stock valued at $6,633,570,000 after acquiring an additional 1,026,985 shares during the period. Geode Capital Management LLC raised its holdings in Colgate-Palmolive by 1.4% during the 4th quarter. Geode Capital Management LLC now owns 22,103,901 shares of the company’s stock valued at $1,754,657,000 after acquiring an additional 304,426 shares during the period. Morgan Stanley raised its holdings in Colgate-Palmolive by 1.7% during the 4th quarter. Morgan Stanley now owns 19,246,217 shares of the company’s stock valued at $1,520,836,000 after acquiring an additional 323,367 shares during the period. Norges Bank bought a new stake in Colgate-Palmolive during the 4th quarter valued at $861,670,000. Finally, Deutsche Bank AG raised its holdings in Colgate-Palmolive by 33.9% during the 4th quarter. Deutsche Bank AG now owns 10,845,857 shares of the company’s stock valued at $857,040,000 after acquiring an additional 2,746,920 shares during the period. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE CL opened at $89.40 on Monday. The company has a 50-day simple moving average of $86.85 and a two-hundred day simple moving average of $86.30. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33. The firm has a market cap of $71.54 billion, a price-to-earnings ratio of 34.79, a PEG ratio of 4.72 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.22 billion. During the same period in the prior year, the business posted $0.91 earnings per share. The company’s revenue was up 8.4% on a year-over-year basis. On average, equities analysts forecast that Colgate-Palmolive Company will post 3.81 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be issued a $0.53 dividend. The ex-dividend date is Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.4%. Colgate-Palmolive’s dividend payout ratio (DPR) is 82.49%.

Wall Street Analyst Weigh In

CL has been the topic of a number of analyst reports. Sanford C. Bernstein initiated coverage on shares of Colgate-Palmolive in a report on Thursday. They set a “market perform” rating and a $96.00 target price on the stock. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 8th. TD Cowen reaffirmed a “hold” rating and issued a $85.00 price target on shares of Colgate-Palmolive in a report on Tuesday, March 31st. Morgan Stanley reaffirmed an “overweight” rating on shares of Colgate-Palmolive in a report on Monday, May 4th. Finally, Rothschild & Co Redburn set a $100.00 price target on shares of Colgate-Palmolive and gave the stock a “buy” rating in a report on Tuesday, April 21st. Twelve research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $95.88.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.